<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-WKTFICXP</identifier><date>2012</date><creator>Cegnar, Mateja</creator><creator>Kerč, Janez</creator><relation>documents/doc/W/URN_NBN_SI_doc-WKTFICXP_001.htm</relation><relation>documents/doc/W/URN_NBN_SI_doc-WKTFICXP_001.pdf</relation><relation>documents/doc/W/URN_NBN_SI_doc-WKTFICXP_001.txt</relation><format format_type="issue">2</format><format format_type="volume">63</format><format format_type="type">article</format><format format_type="extent">str. 82-87</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">1501788</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-WKTFICXP</identifier><language>eng</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">industrija</subject><subject language_type_id="slv">nanotehnologija</subject><subject language_type_id="slv">nanozdravila</subject><subject language_type_id="slv">regulativa</subject><title>Nanomedicines</title><title>Nanozdravila</title></Record>